Does treatment guided by exhaled nitric oxide fraction improve outcomes in subgroups of children with asthma?

Autor: Katherine Pike, Peter J. Gergen, Mariëlle W. Pijnenburg, Johan C. de Jongste, Helen L. Petsky, Françoise Vermeulen, Shona S. Fielding, Maria Fritsch, Thomas Frischer, Robin Vael, Steve S. Turner, Graham Roberts, Stanley J. Szefler, Anne B. Chang

Publikováno v: The European respiratory journal, 55(5). European Respiratory Society
The European respiratory journal

IntroductionExhaled nitric oxide fraction (FENO), a biomarker of eosinophilic airway inflammation, may be useful to guide asthma treatment. FENO-guided treatment may be more effective in certain subgroups for improving asthma outcomes compared to sta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b0b2ce4057ecb5766eeac2cbd58fdfb
https://doi.org/10.1183/13993003.01879-2019

The impact of travel time to cancer treatment centre on post-diagnosis care and mortality among cancer patients in Scotland.

Autor: Turner M; Institute of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK. Electronic address: m.e.turner@abdn.ac.uk., Carriere R; Population Health Sciences Institute, Campus of Ageing and Vitality, Newcastle University, Newcastle, NE4 5PL, UK., Fielding S; Institute of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK., Ramsay G; Aberdeen Royal Infirmary, NHS Grampian, Foresterhill Health Campus, Foresterhill Road, Aberdeen, AB25 2ZN, UK., Samuel L; School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZN, UK., Maclaren A; Institute of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK., Murchie P; Institute of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK.

Publikováno v: Health & place [Health Place] 2023 Nov; Vol. 84, pp. 103139. Date of Electronic Publication: 2023 Nov 16.

Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer.

Autor: Nuciforo P; Vall d'Hebron Institute of Oncology, Barcelona Spain. SOLTI, Barcelona, Spain. Electronic address: pnuciforo@vhio.net., Townend J; Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK., Piccart MJ; Institut Jules Bordet, Université Libre de Bruxelles (ULB) Brussels, Belgium., Fielding S; Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK., Gkolfi P; Global Drug Development, Novartis, Basel, Switzerland., El-Abed S; Breast International Group, Brussels, Belgium., de Azambuja E; Institut Jules Bordet, Université Libre de Bruxelles (ULB) Brussels, Belgium., Werutsky G; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil., Bliss J; The Institute of Cancer Research ICR-CTSU, London, UK., Moebus V; Dept. of Medicine II, Hematology & Oncology University of Frankfurt, Frankfurt, Germany., Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy., Aspitia AM; Jacoby Center for Breast Health, Mayo Clinic, Jacksonville, FL, USA., Gomez H; National Institute of Neoplastic Diseases Ricardo Palma University Lima, Peru., Gombos A; Institut Jules Bordet, Université Libre de Bruxelles (ULB) Brussels, Belgium., Coccia-Portugal MA; Coccia-Portugal M, Eastleigh Breast Care Centre, Pretoria, South Africa., Tseng LM; Taipei-Veterans General Hospital, National Yang Ming Chiao Tung University, Taipei, Taiwan., Kunz G; Dept. Obstet./Gyn., St.-Johannes-Hospital, Dortmund, Germany., Lerzo G; Fundación CENIT Para La Investigación Ciudad Autónoma de Buenos Aires, Argentina., Sohn J; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Semiglazov V; Breast Cancer Department, N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russian Federation., Saura C; Vall d'Hebron Institute of Oncology, Barcelona Spain. SOLTI, Barcelona, Spain., Kroep J; Department Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. Dutch Breast Cancer Oncology Group (BOOG), the Netherlands., Ferro A; Department of Medical Oncology, Rete Clinica Senologica- Santa Chiara Hospital, Trento, Italy., Cameron D; Edinburgh Cancer Research, The University of Edinburgh, Institute of Genetics and Cancer, Crewe Road South, Edinburgh, UK., Gelber R; Department of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, Frontier Science Foundation, Boston, MA, USA., Huober J; Cantonal Hospital St.Gallen | Breast Center | St.Gallen, Switzerland. University of Ulm, Breast Center, Ulm, Germany., Di Cosimo S; Integrated Biology Platform, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Mar; Vol. 181, pp. 92-101. Date of Electronic Publication: 2022 Dec 27.

Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial.

Autor: Turner S; Royal Aberdeen Children's Hospital, University of Aberdeen, Aberdeen, UK. Electronic address: s.w.turner@abdn.ac.uk., Cotton S; Health Services Research Unit, University of Aberdeen, Aberdeen, UK., Wood J; Health Services Research Unit, University of Aberdeen, Aberdeen, UK., Bell V; Health Services Research Unit, University of Aberdeen, Aberdeen, UK., Raja EA; Department of Medical Statistics, University of Aberdeen, Aberdeen, UK., Scott NW; Department of Medical Statistics, University of Aberdeen, Aberdeen, UK., Morgan H; Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK., Lawrie L; Health Services Research Unit, University of Aberdeen, Aberdeen, UK., Emele D; Health Services Research Unit, University of Aberdeen, Aberdeen, UK., Kennedy C; Health Economics Research Unit, University of Aberdeen, Aberdeen, UK., Scotland G; Health Economics Research Unit, University of Aberdeen, Aberdeen, UK., Fielding S; Department of Medical Statistics, University of Aberdeen, Aberdeen, UK., MacLennan G; Health Services Research Unit, University of Aberdeen, Aberdeen, UK., Norrie J; Edinburgh Clinical Trials Unit, University of Edinburgh, Edinburgh, UK., Forrest M; Health Services Research Unit, University of Aberdeen, Aberdeen, UK., Gaillard EA; Department of Respiratory Sciences, University of Leicester, Leicester, UK., de Jongste J; Erasmus University Medical Centre, Rotterdam, Netherlands., Pijnenburg M; Erasmus University Medical Centre, Rotterdam, Netherlands., Thomas M; Primary Care and Population Sciences, University of Southampton, Southampton, UK., Price D; Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK; Observational and Pragmatic Research Institute, Singapore.

Publikováno v: The Lancet. Respiratory medicine [Lancet Respir Med] 2022 Jun; Vol. 10 (6), pp. 584-592. Date of Electronic Publication: 2022 Jan 31.

Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS).

Autor: Cotton S; Centre for Healthcare Randomised Trials (CHaRT), University of Aberdeen, Aberdeen, AB25 2ZD, UK., Devereux G; Centre for Healthcare Randomised Trials (CHaRT), University of Aberdeen, Aberdeen, AB25 2ZD, UK. graham.devereux@lstmed.ac.uk.; Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK. graham.devereux@lstmed.ac.uk., Abbas H; Division of Applied Medicine, University of Aberdeen, Aberdeen, AB25 2ZD, UK., Briggs A; Institute of Health & Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow, G12 8RZ, UK., Campbell K; Centre for Healthcare Randomised Trials (CHaRT), University of Aberdeen, Aberdeen, AB25 2ZD, UK., Chaudhuri R; Gartnavel General Hospital, University of Glasgow, Glasgow, G12 0YN, UK., Choudhury G; Royal Infirmary of Edinburgh, Edinburgh, EH16 4SA, UK., Dawson D; Division of Applied Medicine, University of Aberdeen, Aberdeen, AB25 2ZD, UK., De Soyza A; University of Newcastle, Medical School, Newcastle Upon Tyne, NE2 4HH, UK., Fielding S; Medical Statistics Team, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, AB25 2ZD, UK., Gompertz S; Queen Elizabeth Hospital Birmingham, Birmingham, B15 2WB, UK., Haughney J; Centre of Academic Primary Care, University of Aberdeen, Aberdeen, AB25 2ZD, UK., Lang CC; Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK., Lee AJ; Medical Statistics Team, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, AB25 2ZD, UK., MacLennan G; Centre for Healthcare Randomised Trials (CHaRT), University of Aberdeen, Aberdeen, AB25 2ZD, UK., MacNee W; MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, EH16 4TJ, UK., McCormack K; Centre for Healthcare Randomised Trials (CHaRT), University of Aberdeen, Aberdeen, AB25 2ZD, UK., McMeekin N; Institute of Health & Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow, G12 8RZ, UK., Mills NL; BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, EH16 4SB, UK., Morice A; Cardiovascular and Respiratory Studies, Castle Hill Hospital, Hull, HU16 5JQ, UK., Norrie J; NINE Edinburgh BioQuarter, University of Edinburgh, 9 Little France Road, Edinburgh, EH16 4UX, UK., Petrie MC; Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TD, UK., Price D; Centre of Academic Primary Care, University of Aberdeen, Aberdeen, AB25 2ZD, UK., Short P; Ninewells Hospital, Dundee, DD1 9SY, UK., Vestbo J; Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, M23 9LT, UK., Walker P; Liverpool University Hospitals Foundation NHS Trust, University Hospital Aintree, Lower Lane, Liverpool, L9 7AL, UK., Wedzicha J; National Heart and Lung Institute, Imperial College, London, SW3 6LY, UK., Wilson A; Department of Medicine, University of East Anglia, Norwich, NR4 7TJ, UK., Lipworth BJ; Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK.

Publikováno v: Trials [Trials] 2022 Apr 14; Vol. 23 (1), pp. 307. Date of Electronic Publication: 2022 Apr 14.